By inhibiting the expression of UCA1 and ZNF281 or increasing the expression of miR‐23b‐3p, it may be possible to improve the sensitivity of CRC cells to 5‐FU and thus improve the therapeutic effect. This evidence concerns the gene ZNF281 and colorectal carcinoma.